World's Best Scientists 2026 revealed!
Sophia N. Karagiannis

Sophia N. Karagiannis

D-Index & Metrics

Immunology

D-Index
52
Citations
8285
World Ranking
4087
National Ranking
359

Sophia N. Karagiannis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sophia N. Karagiannis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 221 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sophia N. Karagiannis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sophia N. Karagiannis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 52 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sophia N. Karagiannis is affiliated with King's College London in the United Kingdom and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research spans several subfields, including Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, and Immunology and Allergy.

The scientist's main topical focus covers areas such as Monoclonal and Polyclonal Antibodies Research, Mast cells and histamine, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, T-cell and B-cell Immunology, and Immune Cell Function and Interaction.

Karagiannis has collaborated frequently with several coauthors, including Heather J. Bax, Jitesh Chauhan, James Spicer, Debra H. Josephs, and Alicia M. Chenoweth, reflecting ongoing partnerships in their research endeavors.

Their work has been published in a variety of scientific venues, with notable recurring contributions to:

  • Allergy
  • Cancers
  • Nature Communications
  • Clinical & Experimental Immunology
  • mAbs

Among their recent papers are:

  • Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action, 2021, European Journal of Immunology
  • Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance, 2020, Cancer Cell
  • Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients, 2021, Cancer Cell
  • WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion, 2020, Nature Communications
  • Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer, 2021, Cancer Research

Best Publications

  • Targeting folate receptor alpha for cancer treatment

    Anthony Cheung;Heather J. Bax;Debra H. Josephs;Kristina M. Ilieva

  • Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation

    Chung-Ching Chu;Niwa Ali;Panagiotis Karagiannis;Paola Di Meglio

  • IgG4 subclass antibodies impair antitumor immunity in melanoma

    Panagiotis Karagiannis;Amy Gilbert;Debra Josephs;Niwa Ali

  • Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma.

    Duaa O. Khair;Heather J. Bax;Silvia Mele;Silvia Crescioli

  • AllergoOncology: the role of IgE-mediated allergy in cancer

    E Jensen-Jarolim;G Achatz;M C Turner;Sophia Karagiannis

  • Diverse matrix metalloproteinase functions regulate cancer amoeboid migration

    Jose L Orgaz;Pahini Pandya;Rimple Dalmeida;Panagiotis Karagiannis

  • Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action.

    Zena N Willsmore;Ben G T Coumbe;Silvia Crescioli;Sara Reci

  • Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs).

    Ricarda M Hoffmann;Ben G T Coumbe;Ben G T Coumbe;Debra H Josephs;Silvia Mele

  • Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.

    Marigoula Georgouli;Cecilia Herraiz;Eva Crosas-Molist;Bruce Fanshawe

  • An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment

    Leena Halim;Marco Romano;Reuben McGregor;Isabel Correa

  • COMPARISON OF IGE AND IGG ANTIBODY-DEPENDENT CYTOTOXICITY IN VITRO AND IN A SCID MOUSE XENOGRAFT MODEL OF OVARIAN CARCINOMA

    Hannah J. Gould;Graham A. Mackay;Sophia N. Karagiannis;Carol M. O'Toole

  • IgE-Antibody-Dependent Immunotherapy of Solid Tumors: Cytotoxic and Phagocytic Mechanisms of Eradication of Ovarian Cancer Cells

    Sophia N. Karagiannis;Marguerite G. Bracher;James Hunt;Natalie McCloskey

  • Myosin II reactivation and cytoskeletal remodeling as a hallmark and a vulnerability in melanoma therapy resistance

    Jose L. Orgaz;Jose L. Orgaz;Eva Crosas-Molist;Eva Crosas-Molist;Amine Sadok;Anna Perdrix-Rosell;Anna Perdrix-Rosell;Anna Perdrix-Rosell

  • Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells

    Sophia N. Karagiannis;Qin Wang;Nick East;Frances Burke

  • TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination

    Gaia Cantelli;Jose L. Orgaz;Irene Rodriguez-Hernandez;Panagiotis Karagiannis

  • Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells

    Panagiotis Karagiannis;Josef Singer;James Hunt;Samuel K. E. Gan

  • A tool kit for rapid cloning and expression of recombinant antibodies

    Tihomir S. Dodev;Panagiotis Karagiannis;Amy E. Gilbert;Debra H. Josephs

  • Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.

    Kristina M. Ilieva;Kristina M. Ilieva;Anthony Cheung;Anthony Cheung;Silvia Mele;Giulia Chiaruttini

  • Epidemiological associations of allergy, IgE and cancer.

    Debra H. Josephs;Debra H. Josephs;James F. Spicer;Christopher J. Corrigan;Hannah J. Gould

  • Revisiting the role of B cells in skin immune surveillance

    Isioma U. Egbuniwe;Sophia N. Karagiannis;Frank O. Nestle;Katie E. Lacy

  • Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients.

    Sultan Abdul-Jawad;Luca Baù;Thanussuyah Alaguthurai;Irene del Molino del Barrio

Frequent Co-Authors

Frank O. Nestle
Frank O. Nestle Deerfield (United States)
Hannah J. Gould
Hannah J. Gould King's College London
Erika Jensen-Jarolim
Erika Jensen-Jarolim Medical University of Vienna
Andrew Tutt
Andrew Tutt Institute of Cancer Research
Philip J. Blower
Philip J. Blower King's College London
Niklas Hammar
Niklas Hammar Karolinska Institute
Christopher Corrigan
Christopher Corrigan King's College London
David E. Thurston
David E. Thurston King's College London
Brian J. Sutton
Brian J. Sutton King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology but looking to diversify their careers in healthcare, several related online degree options can provide valuable pathways. Accelerated programs allow students to fast-track their education and enter the workforce sooner. For example, 12-month accelerated nursing programs online for non nurses are designed to help individuals without a nursing background become registered nurses quickly.

If you’re aiming for a Bachelor of Science in Nursing, exploring accelerated BSN programs for non nurses can be a practical approach. These accelerated BSN programs streamline prerequisites and clinical experiences to accommodate learners transitioning from other fields.

For those seeking a quicker entry point into nursing, it’s worth considering programs like which LPN programs are easiest to get into. Licensed Practical Nurse programs often have more flexible admissions and shorter durations, making them accessible options for many.

Finally, to advance clinical expertise and autonomy, one might look into the easiest nurse practitioner degree programs. These programs typically focus on removing barriers in admissions while maintaining quality education, allowing graduates to play critical roles in patient care and specialized services.

Best Scientists Citing Sophia N. Karagiannis

Trending Scientists